dronabinol has been researched along with Prostatic Neoplasms in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gorter, RW | 1 |
Cristino, L; De Petrocellis, L; Di Marzo, V; Iappelli, M; Ligresti, A; Orlando, P; Schiano Moriello, A; Stott, CG; Verde, R | 1 |
Büchele, B; Gschwend, JE; Kneer, L; Maier, L; Nett, C; Rockemann, M; Schneider, M; Seeling, W; Simmet, T; Steffen, P | 1 |
Díaz-Laviada, I; Miguel, A; Ruiz, L | 1 |
Díaz-Laviada, I; Ruiz, L; Sánchez, MG; Velasco, L | 1 |
1 trial(s) available for dronabinol and Prostatic Neoplasms
Article | Year |
---|---|
[Delta(9)-tetrahydrocannabinol and the opioid receptor agonist piritramide do not act synergistically in postoperative pain].
Topics: Aged; Analgesia, Patient-Controlled; Analgesics, Opioid; Arousal; Body Temperature; Double-Blind Method; Dronabinol; Drug Interactions; Hemodynamics; Humans; Lymph Node Excision; Male; Pain Measurement; Pain, Postoperative; Pirinitramide; Prostatectomy; Prostatic Neoplasms; Receptors, Opioid, mu; Respiratory Mechanics | 2006 |
4 other study(ies) available for dronabinol and Prostatic Neoplasms
Article | Year |
---|---|
[Experiences with dronabinol (delta-tetrahydrocannabinol) in oncological patients with anorexia-cachexia syndrome. Illustration of clinical problems and therapy based on 2 case reports].
Topics: Affect; Aged; Analgesics, Non-Narcotic; Anorexia; Bone Neoplasms; Breast Neoplasms; Cachexia; Chronic Pain; Combined Modality Therapy; Dronabinol; Drug Substitution; Drug Therapy, Combination; Female; Humans; Male; Narcotics; Palliative Care; Phytotherapy; Plant Extracts; Prostatic Neoplasms; Quality of Life | 2004 |
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms.
Topics: Androgen Antagonists; Anilides; Animals; Apoptosis; Cannabidiol; Cannabinoids; Caspase 3; Cell Cycle; Cell Survival; Docetaxel; Down-Regulation; Dronabinol; Drug Interactions; Humans; Male; Mice; Mice, Nude; Nitriles; Prostate; Prostatic Neoplasms; Reactive Oxygen Species; Receptors, Androgen; Taxoids; Tosyl Compounds; Transient Receptor Potential Channels; TRPM Cation Channels; Tumor Cells, Cultured | 2013 |
Delta9-tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism.
Topics: Annexin A5; Apoptosis; Benzoxazines; DNA Fragmentation; Dronabinol; Fluorescent Antibody Technique; Humans; Indoles; Male; Mitochondria; Morpholines; Naphthalenes; Pertussis Toxin; Piperidines; Prostatic Neoplasms; Protein Binding; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Sphingosine; Time Factors; Tumor Cells, Cultured; Virulence Factors, Bordetella | 1999 |
delta(9)-Tetrahydrocannabinol increases nerve growth factor production by prostate PC-3 cells. Involvement of CB1 cannabinoid receptor and Raf-1.
Topics: Dose-Response Relationship, Drug; Dronabinol; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Humans; Immunoblotting; Male; Nerve Growth Factor; Pertussis Toxin; Piperidines; Prostatic Neoplasms; Protein Binding; Proto-Oncogene Proteins c-raf; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Time Factors; Tumor Cells, Cultured; Virulence Factors, Bordetella | 2001 |